undamentalytics Newsletter

Macuga Daniel A.: insider trades

Officer at Usana Health Sciences Inc. No open-market purchases and 22 sales not made under a pre-set plan, reported from February 14, 2012 to May 2, 2024.

What happened after Macuga Daniel A.’s sales?

After their sales, the shares moved −10.7% against the index over 12 months on average (a negative figure means selling was the right call); 68% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Macuga Daniel A.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 22 +1.0% −1.1% 55% 12 0.28 0.79 No reliable evidence
Sales, 12 months after the report 22 −10.7% −31.1% 68% 12 −0.48 0.64 No reliable evidence
Sales, 12 months after the trade 22 −11.0% −30.3% 73% 12 −0.54 0.60 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Usana Health Sciences Inc USNA CHIEF COMMUNICATIONS OFFICER022February 14, 2012May 2, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 2, 2024May 2, 2024 USNA Sale $178,708 −15.0%−48.8%−51.6%
March 4, 2024March 1, 2024 USNA Sale $72,120 0.0%−44.5%−51.3%
June 15, 2023June 14, 2023 USNA Sale $140,474 −4.2%−51.8%−52.4%
February 21, 2023February 17, 2023 USNA Sale $187,407 −1.4%−49.3%−44.8%
December 6, 2022December 5, 2022 USNA Sale $79,478 +14.4%−25.5%−29.2%
December 8, 2021December 8, 2021 USNA Sale $37,116 −8.7%−34.1%−34.3%
February 24, 2021February 22, 2021 USNA Sale $361,560 −0.8%−23.9%−15.3%
April 27, 2020April 27, 2020 USNA Sale $387,328 −16.5%−42.4%−37.3%
February 10, 2020February 6, 2020 USNA Sale $277,600 +17.4%+4.9%−13.9%
September 11, 2018September 7, 2018 USNA Sale $1,337,359 +3.8%−51.0%−46.8%
September 6, 2018September 4, 2018 USNA Sale $318,981 +5.2%−46.8%−49.6%
July 30, 2018July 27, 2018 USNA Sale $66,597 −10.7%−55.1%−56.1%
August 30, 2017August 30, 2017 USNA Sale $707,528 +13.5%+103.4%+101.1%
August 29, 2017August 25, 2017 USNA Sale $345,060 +14.0%+101.1%+102.8%
August 16, 2016August 15, 2016 USNA Sale $1,262,632 −6.3%−28.2%−31.3%
May 15, 2015May 13, 2015 USNA Sale $585,204 +25.7%−4.6%+1.0%
May 11, 2015May 7, 2015 USNA Sale $531,573 +32.9%+0.1%+0.6%
June 10, 2014June 6, 2014 USNA Sale $499,077 −6.8%+70.7%+67.5%
August 2, 2013August 1, 2013 USNA Sale $412,554 −21.1%−35.2%−37.8%
July 29, 2013July 25, 2013 USNA Sale $348,286 −9.1%−40.4%−26.2%
August 2, 2012July 30, 2012 USNA Sale $343,880 −8.6%+54.9%+63.4%
February 14, 2012February 13, 2012 USNA Sale $172,093 +3.9%+12.2%−1.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Macuga Daniel A. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.